SeQure®
The only reflux control microcatheter enabling flow directed embolization. Deliver more 1 Reduce the risk of nontarget embolization2,3.
Based on DraKon® microcatheter technology, SeQure® optimizes flexibility4, pushability and torqueability5 for improved trackability 4,5,6.
Improve EmbolizationAllows Increased And Targeted Delivery Of Embolic Material7 |
No Learning Curve |
Beads volume collected until reflux observed (data from vitro investigations) 7 |
|
Embolization of hepatic artery with SEQURE® microcatheter in swine animal model using 100 µm microspheres
"No more blush of the prostate arteries, all vessels surrounded are still very patent so SeQure® made an excellent job in those small and tortuous vessels."
"Not an easy embolization, very tortuous vessels and SeQure® microcatheter did a great job in this case. After embolization, all vessels are patent and only the tumor feeder is embolized, and there is no more tumor blush."
"Nice stasis inside the target vessels and full patency of side vessel branches at final angiogram so they were well protected."
"Static flow in the treated vessels (Segment 5) but still good perfusion in Segment 8 branch so SeQure® worked well from that perspective."
Sequre® is compatible with microspheres > 70 µm.
1. Beads accumulation reports DR-1800178 & TR-026
2. Vessel Flow Dynamic Indication (Beads Reflux) Bench Test report TR-002
3. Usability, Safety and Efficacy of a Novel Microcatheter for Reducing Non-Target Embolization. Michael Tal et al. WCIO 2018 Poster. Animal study
4. TR-025 Flexibility Bench Test
5. TR-006 Torque Transmission Bench Test
6. TR-017 Trackability Bench Test
7. DR-1800178 report & TR-002 Vessel Flow Dynamic Indication Bench Test
Sequre® microcatheters are class IIb medical devices intended for use by interventional radiologists and interventional oncologists for the infusion of contrast media into all peripheral vessels and for drug infusion in intra-arterial therapy, and infusion of embolic materials. They should not be used in cerebral vessels.
For complete information about precautions and optimal usage conditions for these medical devices, we recommend consulting the instructions for use supplied with each device or with your local Guerbet representative(s). Information for use only in countries with applicable health authority registrations. Notified Body: MedCert 0482. Manufacturer: Accurate Medical Therapeutics Ltd. EC Rep: Guerbet. Document creation date: September 2019. Sequre® is a registered trademark of Guerbet Group or its affiliates.
Illustrations for information purposes – not indicative of actual size or clinical outcome.
P21001026